Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q6PCE3
UPID:
PGM2L_HUMAN
Alternative names:
PMMLP; Phosphoglucomutase-2-like 1
Alternative UPACC:
Q6PCE3; Q96MQ7; Q9UIK3
Background:
Glucose 1,6-bisphosphate synthase, also known as Phosphoglucomutase-2-like 1 (PMMLP), plays a pivotal role in glucose metabolism. It catalyzes the synthesis of glucose 1,6-bisphosphate from 1,3-bisphosphoglycerate, impacting various sugars including glucose 1-phosphate and mannose 1-phosphate. Despite its low phosphopentomutase and phosphoglucomutase activity, its primary function is crucial for cellular energy management.
Therapeutic significance:
The protein is linked to a neurodevelopmental disorder characterized by developmental delay, dysmorphic facial features, and skin abnormalities. Understanding the role of Glucose 1,6-bisphosphate synthase could open doors to potential therapeutic strategies for this disorder, highlighting its significance in medical research.